SCHEMBL6840131

SCHEMBL6840131

Cc1ccc(NC(=O)N2CCCOc3ccc(/C=C4/SC(=S)NC4=O)cc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 14/20 0.53
CSNK2A2 P19784 1/20 0.49
CLK1 P49759 1/20 0.49
CSNK2B P67870 1/20 0.49
CSNK2A1 P68400 1/20 0.49
DYRK1A Q13627 1/20 0.49
DYRK2 Q92630 1/20 0.49
DYRK1B Q9Y463 1/20 0.49
MAPT P10636 1/20 0.46
ADAMTS5 Q9UNA0 1/20 0.45
NAT1 P18440 1/20 0.44
PPARG P37231 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
NPC1 O15118 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6840132 1.00 PIK3CG (0.53) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6188005 0.95 PIK3CG (0.54) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6188008 0.95 PIK3CG (0.54) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6835911 0.86 PIK3CG (0.53) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6835909 0.86 PIK3CG (0.53) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6187279 0.86 PIK3CG (0.53) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6187282 0.86 PIK3CG (0.53) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6176750 0.83 CSNK2A2 (0.58) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6175239 0.83 CSNK2A2 (0.58) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1
SCHEMBL6185491 0.81 PIK3CG (0.54) PIK3CGCSNK2A2CLK1CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138199-A1 Benzoxazines and derivatives thereof as therapeutic agents GOGLIOTTI ROCCO DEAN (US) 2004-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138199-A1 Benzoxazines and derivatives thereof as therapeutic agents XDH, TBXA2R, TBXAS1 PIK3CG 4543/4885CSNK2A2 1130/4885CLK1 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.